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Abstract
Background
Estimating multimorbidity (presence of two or more chronic conditions) using administrative data is
becoming increasingly common. We investigated (1) the concordance of identification of chronic conditions
and multimorbidity using self-report survey and administrative datasets; (2) characteristics of people with
multimorbidity ascertained using different data sources; and (3) whether the same individuals are classified as
multimorbid using different data sources.
Methods
Baseline survey data for 90,352 participants of the 45 and Up Study—a cohort study of residents of New
South Wales, Australia, aged 45 years and over—were linked to prior two-year pharmaceutical claims and
hospital admission records. Concordance of eight self-report chronic conditions (reference) with claims and
hospital data were examined using sensitivity (Sn), positive predictive value (PPV), and kappa (κ).The
characteristics of people classified as multimorbid were compared using logistic regression modelling.
Results
Agreement was found to be highest for diabetes in both hospital and claims data (κ = 0.79, 0.78; Sn = 79%,
72%; PPV = 86%, 90%). The prevalence of multimorbidity was highest using self-report data (37.4%),
followed by claims data (36.1%) and hospital data (19.3%). Combining all three datasets identified a total of
46 683 (52%) people with multimorbidity, with half of these identified using a single dataset only, and up to
20% identified on all three datasets. Characteristics of persons with and without multimorbidity were
generally similar. However, the age gradient was more pronounced and people speaking a language other than
English at home were more likely to be identified as multimorbid by administrative data.
Conclusions
Different individuals, with different combinations of conditions, are identified as multimorbid when different
data sources are used. As such, caution should be applied when ascertaining morbidity from a single data
source as the agreement between self-report and administrative data is generally poor. Future multimorbidity
research exploring specific disease combinations and clusters of diseases that commonly co-occur, rather than
a simple disease count, is likely to provide more useful insights into the complex care needs of individuals with
multiple chronic conditions.
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Abstract
Background
Estimating multimorbidity (presence of two or more chronic conditions) using administrative
data is becoming increasingly common. We investigated (1) the concordance of identifica-
tion of chronic conditions and multimorbidity using self-report survey and administrative
datasets; (2) characteristics of people with multimorbidity ascertained using different data
sources; and (3) whether the same individuals are classified as multimorbid using different
data sources.
Methods
Baseline survey data for 90,352 participants of the 45 and Up Study—a cohort study of resi-
dents of New South Wales, Australia, aged 45 years and over—were linked to prior two-
year pharmaceutical claims and hospital admission records. Concordance of eight self-
report chronic conditions (reference) with claims and hospital data were examined using
sensitivity (Sn), positive predictive value (PPV), and kappa (κ).The characteristics of people
classified as multimorbid were compared using logistic regression modelling.
Results
Agreement was found to be highest for diabetes in both hospital and claims data (κ = 0.79,
0.78; Sn = 79%, 72%; PPV = 86%, 90%). The prevalence of multimorbidity was highest
using self-report data (37.4%), followed by claims data (36.1%) and hospital data (19.3%).
Combining all three datasets identified a total of 46 683 (52%) people with multimorbidity,
with half of these identified using a single dataset only, and up to 20% identified on all three
datasets. Characteristics of persons with and without multimorbidity were generally similar.
However, the age gradient was more pronounced and people speaking a language other
than English at home were more likely to be identified as multimorbid by administrative data.
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Conclusions
Different individuals, with different combinations of conditions, are identified as multimorbid
when different data sources are used. As such, caution should be applied when ascertaining
morbidity from a single data source as the agreement between self-report and administra-
tive data is generally poor. Future multimorbidity research exploring specific disease combi-
nations and clusters of diseases that commonly co-occur, rather than a simple disease
count, is likely to provide more useful insights into the complex care needs of individuals
with multiple chronic conditions.
Introduction
Chronic diseases are the leading cause of illness, disability and death, accounting for 68% of
global [1] and 90% of all Australian deaths [2]. The prevalence of chronic conditions has been
increasing over the past forty years [3], with the greatest growth seen in the concurrent pres-
ence of multiple chronic diseases (known as multimorbidity [4]), attributable to the ageing
population, and advances in medical care and public health policy [5, 6]. One third of the Aus-
tralian population [7] are estimated to have multimorbidity, with up to 80% of those aged 65
and over having three or more chronic conditions [8].
Appropriate and accurate measurement of the prevalence of chronic disease and multimor-
bidity is essential in order to monitor trends, estimate burden of disease, target preventive
measures, and plan treatment and care delivery. A variety of data sources are used for monitor-
ing, including population health surveys, disease registries and administrative databases
(including primary health care, hospitalisation and medication data), with the use of the latter
becoming increasingly common due to its efficient capture, ease of use and inexpensive nature
[9]. However, the use of administrative data is not without drawbacks. These data have differ-
ent levels of capture of chronic disease, and variable data quality [10–14]. Furthermore, not all
patients with chronic diseases use hospital services, and even when they do, their admission
record may not capture all of their conditions. Medication data, on the other hand, present a
different set of challenges. In some instances, prescribed medications are clearly linked to the
treatment of a specific chronic condition (e.g. insulin in diabetic patients). In other cases, med-
ications may have multiple indications (e.g. β-blockers for heart failure and high blood pres-
sure). The majority of Australian studies of multimorbidity have estimated multimorbidity
using self-report data [15–19].
Research on comparative estimates of multimorbidity derived using different data sources
is scarce. The majority of multimorbidity studies use only one dataset (for example [17–21]),
with only a handful of studies [22–27] examined the difference in prevalence estimates
between data sources. These studies found differences in estimates of multimorbidity, but
these were largely attributable to differing study populations and numbers of conditions
counted in the multimorbidity definition. Even when trying to standardise the multimorbidity
definition by using the same list of chronic conditions [26] or comparing multimorbidity
within the same sample [24], no study has examined whether the same people, using the same
list of chronic conditions, are classified as multimorbid using different data sources.
The current study used record linkage of self-report survey data from a large cohort study
with two sets of administrative data to compare ascertainment of common chronic conditions.
Specific aims were to investigate: (1) the concordance of identification of chronic conditions
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and multimorbidity using self-report and administrative datasets; (2) the similarities and dif-
ferences between people with multimorbidity ascertained using different datasets; and (3)
whether the same individuals are classified as multimorbid using different data sources.
Methods
Data sources
The 45 and Up Study. The 45 and Up Study is a large-scale cohort study involving
266,950 men and women aged 45 years and over from the general population of New South
Wales, Australia’s most populous state. The study is described in detail elsewhere [28]. In brief,
participants in the 45 and Up Study were randomly sampled from the Department of Human
Services (formerly Medicare Australia) enrolment database, which provides near complete
coverage of the population. People 80+ years of age and residents of rural and remote areas
were oversampled. Participants joined the Study by completing a baseline questionnaire
between February 2005 and March 2009 and giving signed consent for linkage of their infor-
mation to routine health databases [28]. Of those invited, about 18% participated and these
comprised about 11% of the NSW population aged 45 and over [28]. The baseline question-
naire was modified over time in an attempt to better capture self-report or doctor-diagnosed
common illnesses. There were three versions of the questionnaire. In version 1, asthma, hayf-
ever and depression were not included. In versions 2 and 3 separate questions for asthma,
hayfever and depression were present [29].
Pharmaceutical Benefits Scheme (PBS). The PBS database contains information on
Commonwealth subsidised claims for prescribed medicines listed on the Schedule of Pharma-
ceutical Benefits [30]. The main PBS beneficiaries include concession card holders (people
aged 65 and over who meet an income test, people with disability, low income or facing a large
burden of dependants) and general beneficiaries. Prior to 2012, only records for PBS-listed
prescription medications for which a government subsidy was paid were recorded on the PBS
data. This resulted in differential capture of prescribed medicines by concession card holders
and general beneficiaries. Capture for concession card holders was complete, as all prescrip-
tion medicines cost more that the concession threshold. However, PBS-medicines falling
below the co-payment threshold for general beneficiaries were not captured in the PBS data.
We therefore restricted our analyses to concession card holders only, to avoid potential incom-
plete capture of medicines dispensed to general beneficiaries. PBS data from 1 September 2005
to 20 December 2011 were linked deterministically to 45 and Up Study questionnaire data by
the Sax Institute, using a unique identifier that was provided to the Department of Human Ser-
vices (DHS). PBS data included date of dispensing, beneficiary status, PBS item code, Anatom-
ical Therapeutic Chemical (ATC) code [31] and quantity supplied. Unless otherwise specified,
the term medication data in the paper refers to the PBS data.
The NSW Admitted Patient Data Collection (APDC). The APDC includes records of all
public and private hospital admissions ending in a separation, i.e. discharge, transfer, type-
change or death. Diagnoses are coded according to the Australian modification of the Interna-
tional Statistical Classification of Diseases and Related Problems 10th Revision, ICD-10-AM
[32]. Up to 55 diagnoses codes are recorded on the APDC, including the principal diagnosis
and up to 54 additional diagnoses. The APDC from 1 July 2000 to 31 December 2013 was
linked probabilistically to survey information from the 45 and Up Study by the NSW Centre
for Health Record Linkage (www.cherel.org.au) using the ‘best practice’ protocol for preserv-
ing privacy [33]. Unless otherwise specified, the term hospital data in the paper refers to the
APDC data.
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Study population
People aged 45 years and over were included in the analysis if they: (a) completed the 45 and
Up Study baseline study questionnaire between 1 September 2007 and 2 March 2009; and (b)
had a PBS record for any prescription medication within 2 years preceding the questionnaire
date (longest lookback available). Only those with consistent PBS concession card holder status
within the 2-year period were included. Information about hospitalisations for these partici-
pants was also obtained from the APDC data, restricted to the same 2-year period as the PBS
data. People who answered version 1 of the 45 and Up Study baseline questionnaire (n = 37
088) were excluded, as it was not possible to ascertain self-report of doctor-diagnosed depres-
sion for these participants. Holders of a Department of Veterans’ Affairs health card (n = 6
299) were also excluded, as the PBS does not capture all the services provided to these individ-
uals. A total of 90 352 people with consistent PBS concession card holder status were included
in the analysis: 46,766 persons with claims data only (medication only); and 43 586 persons
with both claims and hospitalisation records (medication + hospitalisation) (S1 Fig)
Morbidity measures
A total of eight chronic conditions (hypertension, cancer, heart disease, stroke, diabetes,
asthma, depression and Parkinson’s disease–hereafter referred to as ‘morbidities’) were
selected for analysis, based on their availability in both self-report and administrative data.
Self-report morbidities were ascertained on the basis of responses to a single question “Has
a doctor ever told you that you have (name of condition)?” in the baseline 45 and Up Study
survey.
Morbidity in the hospital data was ascertained using ICD-10-AM codes in any of the 55
diagnosis fields (S1 Table). The initial list of eligible ICD-10 codes was obtained from the
Charlson Index [34, 35] and Elixhauser Index [36, 37], and refined following advice from a
clinical coder. If a condition was coded at least once in the 2-year lookback period, then a per-
son was coded as having that condition in the hospital data.
Morbidity in the medication data was ascertained using ATC codes obtained from Rx-
Risk-V [38, 39], published reports [40], and research articles [41–47]. A person was coded as
having conditions of interest if a specific ATC code was present in the medication data at least
twice in the 2-year lookback period, as it was expected that chronic condition medications
would be used regularly. Where published literature had different ATC codes, we chose the
codes that had the highest positive predictive value (S1 Table).
A count of conditions in each of the three datasets (self-report, medication and hospital)
was created by summing the total number of chronic conditions, ranging from 0 to 8, as well
as the total when stroke was excluded. Multimorbidity was defined as having two or more
chronic conditions, which is the most commonly used definition in the literature [48]. Com-
plex multimorbidity was defined as having three or more chronic conditions affecting three or
more body systems [49].
Statistical methods
Measures of agreement. Agreement between the three data sources was measured by esti-
mating sensitivity (Sn), specificity (Sp), positive predictive value (PPV), negative predictive
value (NPV) and Cohen’s kappa statistic (κ) using self-report morbidity measures as the refer-
ence. Sensitivity represents the percentage of those with a condition (according to self-report)
who were correctly identified as having that condition in administrative data. Specificity repre-
sents the percentage of those without a self-report condition who did not have a condition in
administrative data. PPV represents the percentage of those identified as having a condition of
Multimorbidity in Australia: Comparing estimates derived using different data sources
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interest in the administrative data, who actually had the condition, according to self-report.
NPV represents the percentage of those identified as not having a condition of interest in the
administrative data, who did not have a condition according to the self-report. The kappa sta-
tistic (κ) represents the proportion agreement corrected for chance. Kappa values above 0.75
denote excellent agreement, 0.40 to 0.75 fair to good agreement and below 0.45 poor agree-
ment [50].
Analysis. Logistic regression was used to model the odds of multimorbidity, within each
dataset separately. All analyses were adjusted for age (categorised into four 10-year age groups
and 85+) and sex, and adjusted odds ratios (aORs) and their corresponding 95% confidence
intervals (CI) were calculated. A range of categorical variables were examined, including
remoteness of residence, highest education attainment, Aboriginal or Torres Strait Islander
origin, country of birth, language other than English spoken at home, household income and
marital status. Information about these variables was obtained from the 45 and Up Study base-
line questionnaire. All data management and analyses were conducted using SAS software,
version 9.3 [51].
Ethical approvals
Ethics approvals for this study were obtained from the NSW Population and Health Services
Research Ethics Committee and the Aboriginal Health & Medical Research Ethics Committee.
The conduct of the 45 and Up Study was approved by the University of New South Wales
Human Research Ethics Committee.
Results
Sample characteristics
The sample comprised 90 352 participants, who all had a PBS record within the 2 years prior
to joining the 45 and Up Study. Forty eight percent of participants also had a hospitalisation in
the same timeframe. The mean age at survey completion was 70.2 years in the full sample, and
71.8 years among those with a hospital record. The median number of self-report conditions
was 1, with hypertension being the most commonly reported. Other characteristics of the
study population are presented in Table 1.
Agreement measures
Table 2 summarises agreement measures for self-report and administrative data for all eight
chronic conditions and multimorbidity definitions. Excellent levels of agreement beyond
chance were only found for diabetes, in both medication and hospital datasets. Fair to good
agreement was found for hypertension, asthma, depression and Parkinson’s disease in the
medication data only. The agreement between self-report and hospital data was generally
poor.
Except for cancer, sensitivity values were found to be higher in medication data (range
51.5% - 72.4%) than the hospital data (range 6.1% - 78.6%) (Fig 1). However, hospital data
exhibited higher levels of PPV across all conditions, with the majority of PPVs higher than
70%. The highest PPV was for cancer (89%) in hospital data, and diabetes (90%) in medication
data.
Prevalence of individual chronic conditions varied by data source, with hypertension iden-
tified in nearly 50% of the sample. Stroke prevalence estimates were found to be four times
greater using medication data than self-report data (22.5% vs 5.6%), so stroke was excluded
from the count of conditions in the remaining analyses.
Multimorbidity in Australia: Comparing estimates derived using different data sources
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Prevalence of multimorbidity
The prevalence of multimorbidity in the study sample was highest using the self-report data
(37.4% in the overall sample, 44.2% among those hospitalised), followed by medication data
(36.1%) and hospital data (19.3%) (Table 2). The highest level of complex multimorbidity was
found among hospitalised patients using the self-report multimorbidity definition (11%).
The prevalence of multimorbidity was higher in males, and increased with age, using all
three data definitions (Fig 2). For those aged under 75 years, the highest prevalence was found
using self-report data. For people aged over 75 years, the estimates, particularly in women,
were higher using medication data. The proportion of persons with multimorbidity was con-
sistently lower in hospital data compared to the other two datasets.
Associations between multimorbidity and key demographic variables were found to be con-
sistent between datasets, with some differences in the magnitudes of these relationships. The
odds of multimorbidity were higher in people who were male, older, of Aboriginal or Torres
Strait Islander origin, widowed/divorced/separated, or lived in remote/very remote areas
(Table 3). Males had higher odds of multimorbidity using hospital data than with medication
data (OR = 1.49 versus OR = 1.07). The age gradient in multimorbidity was more pronounced
using administrative data than self-report data (OR>2.5 versus OR = 1.83 for those aged 75–
84). People speaking a language other than English at home had 6% higher odds of having
multimorbidity (OR = 1.06, 95% CI 1.01–1.10) using medication data and 32% higher odds
using hospital data (OR = 1.32, 95% CI 1.22–1.42), but 20% lower odds (OR = 0.80, 95% CI
0.76–0.84) of multimorbidity using self-report data.
Agreement in multimorbidity between datasets
A total of 46 683 (52%) people were found to have multimorbidity in any of the three datasets–
33 768 using self-report data, and an additional 12 915 using administrative data only. Of all
multimorbid cases, half were identified using a single dataset only, and around one in ten
Table 1. Characteristics of the study population.
Medication + Hospitalisation
(N = 43,586)
Full sample
(N = 90,352)
Mean age, years (standard deviation) 71.8 (9.7) 70.2 (10.2)
Median number of self-report chronic conditions (range) 1 (0–8) 1 (0–8)
Median number of self-report chronic conditions (exc stroke)
(range)
1 (0–7) 1 (0–7)
Male sex, n (%) 20,509 (47.1) 40,032 (44.3)
Born overseas, n (%) 10,300 (23.6) 22,575 (25.0)
Speaks language other than English at home, n (%) 4,173 (9.6) 9,525 (10.5)
Aboriginal or Torres Strait Islander, n (%) 410 (0.9) 904 (1.0)
Self-report conditions: % with this
condition
% with 1+ other
conditions
% with this
condition
% with 1+ other
conditions
Hypertension 48.7 70.6 46.2 63.8
Cancer 26.4 75.2 20.9 73.1
Heart disease 23.9 82.2 18.5 80.6
Stroke 7.3 88.8 5.6 87.8
Diabetes 15.2 87.7 13.6 84.4
Asthma 14.0 82.3 12.6 77.8
Depression 16.2 79.0 15.7 72.8
Parkinson’s 1.2 85.5 1.0 83.3
https://doi.org/10.1371/journal.pone.0183817.t001
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Table 2. Measures of agreement between self-report chronic conditions and administrative data, 2-year lookback.
Chronic
condition
Sn (95% CI) PPV (95% CI) Sp (95% CI) NPV (95%CI) Kappa Prevalence admin
data
Prevalence self-
report
Relative
difference
Hospital data (n = 43,586)3
Hypertension 34.5 (33.9–
35.2)
72.7 (71.8–
73.6)
87.7 (87.2–
88.1)
58.5 (57.9–
59.0)
0.23 23.1% 48.7% -53%
Cancer 17.9 (17.2–
18.6)
89.0 (87.7–
90.2)
99.2 (99.1–
99.3)
77.1 (76.7–
77.5)
0.23 5.3% 26.4% -80%
Heart disease 44.4 (43.4–
45.3)
59.0 (57.9–
60.1)
90.3 (90.0–
90.6)
83.8 (83.4–
84.2)
0.38 18.0% 23.9% -25%
Stroke 13.2 (12.0–
14.4)
74.7 (71.0–
78.2)
99.7 (99.6–
99.7)
93.6 (93.4–
93.8)
0.21 1.3% 7.3% -82%
Diabetes 78.6 (77.6–
79.6)
86.1 (85.2–
86.9)
97.7 (97.6–
97.9)
96.2 (96.0–
96.4)
0.79 13.8% 15.2% -9%
Asthma 6.9 (6.3–7.5) 80.8 (77.2–
83.9)
99.7 (99.7–
99.8)
86.8 (86.5–
87.1)
0.11 1.2% 14.0% -91%
Depression 6.1 (5.6–6.7) 70.5 (66.7–
73.9)
99.5 (99.4–
99.6)
84.6 (84.2–
84.9)
0.09 1.4% 16.2% -91%
Parkinsons’s 29.1 (25.4–
33.0)
82.5 (76.5–
87.3)
99.9 (99.9–
99.9)
99.1 (99.0–
99.2)
0.43 0.4% 1.2% -65%
MM1 33.5 (32.8–
34.2)
76.7 (75.8–
77.6)
91.9 (91.6–
92.3)
63.6 (63.1–
64.1)
0.27 19.3% 44.2% -56%
Complex MM2 7.4 (6.7–8.1) 67.9 (63.8–
71.8)
99.6 (99.5–
99.6)
89.7 (89.4–
90.0)
0.11 1.2% 11.0% -89%
Medication data (n = 90,352)4
Hypertension 62.2 (61.7–
62.6)
79.9 (79.4–
80.3)
86.6 (86.3–
86.9)
72.7 (72.4–
73.1)
0.50 35.9% 46.2% -22%
Cancer 4.5 (4.2–4.8) 47.6 (45.3–
50.0)
98.7 (98.6–
98.8)
79.6 (79.3–
79.9)
0.05 2.0% 20.9% -91%
Heart disease 67.9 (67.2–
68.6)
35.3 (34.7–
35.8)
71.7 (71.3–
72.0)
90.8 (90.5–
91.0)
0.29 35.7% 18.5% 93%
Stroke 64.1 (62.8–
65.4)
16.0 (15.5–
16.5)
80.0 (79.8–
80.3)
97.4 (97.3–
97.5)
0.18 22.5% 5.6% 300%
Diabetes 72.4 (71.7–
73.2)
90.0 (89.4–
90.5)
98.7 (98.6–
98.8)
95.8 (95.6–
95.9)
0.78 11.0% 13.6% -19%
Asthma 65.4 (64.6–
66.3)
57.3 (56.5–
58.2)
93.0 (92.8–
93.2)
94.9 (94.8–
95.1)
0.55 14.4% 12.6% 14%
Depression 51.5 (50.7–
52.3)
66.4 (65.5–
67.3)
95.1 (95.0–
95.3)
91.3 (91.1–
91.5)
0.51 12.2% 15.7% -22%
Parkinson’s 58.9 (55.7–
62.0)
53.3 (50.3–
56.4)
99.5 (99.4–
99.5)
99.6 (99.5–
99.6)
0.56 1.1% 1.0% 10%
MM1 60.4 (59.8–
60.9)
62.5 (62.0–
63.0)
78.4 (78.0–
78.7)
76.8 (76.5–
77.2)
0.39 36.1% 37.4% -3%
Complex MM2 24.7 (23.7–
25.6)
56.2 (54.5–
57.8)
98.2 98.1–
98.2)
93.2 (93.0–
93.3)
0.31 3.8% 8.7% -56%
Medication or hospital data (n = 90,352)5
Hypertension 66.2 (65.8–
66.7)
78.0 (77.6–
78.5)
84.0 (83.7–
84.3)
74.4 (74.0–
74.7)
0.51 39.2% 46.2% -15%
Cancer 13.1 (12.6–
13.5)
68.5 (66.9–
70.0)
98.4 (98.3–
98.5)
81.0 (80.8–
81.3)
0.16 4.0% 20.9% -81%
Heart disease 73.1 (72.4–
73.8)
35.7 (35.2–
36.2)
70.0 (69.7–
70.4)
92.0 (91.7–
92.2)
0.31 38.0% 18.5% 105%
Stroke 65.8 (64.5–
67.1)
16.3 (15.8–
16.8)
79.9 (79.7–
80.2)
97.5 (97.4–
97.6)
0.19 22.6% 5.6% 303%
(Continued )
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Table 2. (Continued)
Chronic
condition
Sn (95% CI) PPV (95% CI) Sp (95% CI) NPV (95%CI) Kappa Prevalence admin
data
Prevalence self-
report
Relative
difference
Diabetes 80.4 (79.7–
81.1)
86.8 (86.2–
87.4)
98.1 (98.0–
98.2)
96.9 (96.8–
97.1)
0.81 12.6% 13.6% -7%
Asthma 65.8 (65.0–
66.7)
57.3 (56.5–
58.2)
92.9 (92.8–
93.1)
95.0 (94.8–
95.1)
0.55 14.5% 12.6% 15%
Depression 52.0 (51.1–
52.8)
66.2 (65.3–
67.0)
95.0 (94.9–
95.2)
91.4 (91.1–
91.6)
0.52 12.4% 15.7% -21%
Parkinson’s 59.5 (56.3–
62.6)
52.6 (49.6–
55.6)
99.4 (99.4–
99.5)
99.6 (99.5–
99.6)
0.55 1.2% 1.0% 13%
MM1 80.4 (80.0–
80.8)
59.7 (59.2–
60.1)
65.1 (64.7–
65.5)
83.8 (83.4–
84.1)
0.43 39.2% 37.4% 5%
Complex MM2 72.0 (71.2–
72.7)
35.9 (35.4–
36.5)
78.5 (78.2–
78.8)
94.4 (94.2–
94.5)
0.36 5.1% 8.7% -41%
Sn: sensitivity; PPV: positive predictive value; Sp: specificity; NPV: negative predictive value
1 Multimorbidity (MM): Presence of two or more chronic conditions, excluding stroke
2 Complex MM: Presence of three or more chronic conditions affecting 3 or more body systems, excluding stroke
3 Conditions ascertained from hospital diagnoses
4 Conditions ascertained from medication codes
5 Conditions ascertained from medication codes (for those without a hospitalisation), or medication or hospitalisation codes (for those with a hospitalisation)
https://doi.org/10.1371/journal.pone.0183817.t002
Fig 1. Agreement between self-report and administrative data sources. Blue circles–Hospital, Red
circles–Medication. Abbreviations: MM–multimorbidity (2+ chronic conditions, excluding stroke); Complex
MM–complex multimorbidity (3+ chronic conditions affecting 3 or more body systems, excluding stroke).
https://doi.org/10.1371/journal.pone.0183817.g001
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(n = 5 333, 11%) were multimorbid on all three datasets (Fig 3A). When the analyses were
restricted to hospitalised patients, the overlap in the datasets increased to 20% (Fig 3B). The
agreement on multimorbidity between datasets was poor, with kappa between 0.27 and 0.39,
increasing to 0.43 when both hospital and medication data were combined (Table 2).
People identified as being multimorbid in only the self-report data had higher prevalence of
cancer, depression, asthma and Parkinson’s disease than those identified only in the adminis-
trative datasets. The most common self-report two-way combinations of morbidities were can-
cer and hypertension (n = 2 177), hypertension and depression (n = 1 243) and a three-way
combination of cancer, hypertension and heart disease (n = 376).
Administrative data, however, were more likely to identify hypertension and heart disease
than self-report, with the heart disease and hypertension two-way combination being the most
prevalent in both medication (n = 7 291) and hospital datasets (n = 323) (data not shown).
Discussion
This record linkage study of self-report, hospital admission and medication data compared
their use for identifying individuals with multimorbidity, based on the most common chronic
conditions in Australia. It showed that the ascertainment of multimorbidity varied between
data sources, and that, even where the estimated prevalence of multimorbidity was similar for
two data sets, the concordance in classification as multimorbid for individual patients was low.
We investigated the level of concordance of identification of eight chronic conditions
between self-report and administrative data. We found that chronic conditions identified in
hospital data had higher PPVs and low sensitivities, indicating that although the hospital data
does not identify all the people with a chronic condition, when such condition is identified, it
is generally accurate. Diagnoses may not always be recorded during inpatient episodes of stay,
Fig 2. Prevalence of multimorbidity, by age group and data source. Black circles, solid line–Self-report
(male); Black circles, broken line–Self-report (female); Red circles, solid line–Medication (male); Red circles,
broken line–Medication (female); Blue circles, solid line–Hospital (male); Blue circles, broken line–Hospital
(female).
https://doi.org/10.1371/journal.pone.0183817.g002
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and there is variation in the level or recording between hospitals [10, 11]. In Australia, until
recently, there was no mechanism to code diagnoses that do not contribute to hospital stay.
Prior to 2015, only diagnoses affecting patient management in a particular episode of care
were coded in administrative hospital data. In 2015 codes for temporary use in Australia were
Table 3. Odds of multimorbidity, by data source.
Variable n (%)1 Self-report data
aOR (95% CI)
Medication data
aOR (95% CI)
Hospital data
aOR (95% CI)
Medication or Hospital data
aOR (95% CI)
Age group2
45–54 (ref) 8,388 (9.3) 1 1 1 1
55–64 15,830 (17.5) 1.51 (1.43, 1.60) 2.08 (1.94,2.22) 1.93 (1.67,2.23) 2.14 (2.00,2.28)
65–74 35,689 (39.5) 1.56 (1.48, 1.64) 2.73 (2.57,2.91) 1.98 (1.73,2.27) 2.81 (2.65,2.99)
75–84 25,441 (28.2) 1.83 (1.73, 1.93) 4.25 (3.99,4.53) 2.59 (2.26,2.96) 4.53 (4.26,4.81)
85+ 5,004 (5.5) 1.62 (1.50, 1.74) 5.13 (4.73,5.55) 3.22 (2.76,3.75) 5.74 (5.31,6.22)
Sex3
Female (ref) 50,320 (55.7) 1 1 1 1
Male 40,032 (44.3) 1.27 (1.23, 1.30) 1.07 (1.04,1.10) 1.49 (1.42,1.57) 1.13 (1.10,1.16)
Remoteness of residence4
Major city (ref) 37,191 (41.2) 1 1 1 1
Inner regional 33,839 (37.5) 1.06 (1.03, 1.09) 0.97 (0.94,1.01) 0.92 (0.87,0.97) 0.97 (0.94,1.00)
Outer regional 17,506 (19.4) 1.00 (0.96, 1.04) 0.98 (0.94,1.02) 0.85 (0.79,0.91) 0.96 (0.93,1.00)
Remote/very remote 1,803 (2.0) 1.14 (1.03, 1.26) 1.11 (1.00,1.23) 1.28 (1.08,1.53) 1.10 (0.99,1.21)
Highest education4
Did not complete school (ref) 42,789 (47.4) 1 1 1 1
High school, apprenticeship, grad dip 35,423 (39.2) 0.95 (0.92, 0.98) 0.80 (0.78,0.83) 0.83 (0.79,0.88) 0.80 (0.78,0.83)
University or higher 9,778 (10.8) 0.90 (0.86, 0.94) 0.65 (0.62,0.68) 0.72 (0.66,0.78) 0.65 (0.62,0.68)
Aboriginal or Torres Strait Islander 4
Non Aboriginal (ref) 87,142 (96.5) 1 1 1 1
Aboriginal 904 (1.0) 1.57 (1.38, 1.80) 1.60 (1.39,1.83) 2.09 (1.68,2.61) 1.66 (1.45,1.91)
Speaks language other than English at home4
English only (ref) 80,827 (89.5) 1 1 1 1
Other language 9,525 (10.5) 0.80 (0.76, 0.84) 1.06 (1.01,1.10) 1.32 (1.22,1.42) 1.05 (1.00,1.10)
Country of birth4
Australia (ref) 66,568 (73.7) 1 1 1 1
Overseas 22,575 (25.0) 0.78 (0.76, 0.81) 0.86 (0.83,0.89) 1.05 (0.99,1.11) 0.86 (0.83,0.89)
Household incom4
<20,000 (ref) 35,726 (39.5) 1 1 1 1
20-50k 26,612 (29.5) 0.79 (0.77, 0.82) 0.73 (0.70,0.75) 0.65 (0.61,0.69) 0.72 (0.70,0.75)
50 - 70k 3,298 (3.7) 0.64 (0.59, 0.69) 0.53 (0.49,0.58) 0.49 (0.42,0.58) 0.54 (0.49,0.58)
70k+ 1,495 (1.7) 0.58 (0.52, 0.66) 0.49 (0.43,0.55) 0.50 (0.40,0.63) 0.47 (0.42,0.53)
Not stated 15,862 (17.6) 0.75 (0.72, 0.78) 0.85 (0.81,0.88) 0.82 (0.77,0.88) 0.85 (0.82,0.88)
Marital status4
Single (ref) 5,774 (6.4) 1 1 1 1
Married/de-facto 58,655 (64.9) 0.88 (0.83, 0.94) 0.96 (0.90,1.02) 0.88 (0.80,0.98) 0.94 (0.89,1.00)
Widowed/divorced/separated 25,246 (27.9) 1.10 (1.03, 1.17) 1.09 (1.02,1.16) 1.09 (0.98,1.22) 1.09 (1.02,1.16)
aOR–odds ratio adjusted for age and sex, unless stated otherwise.
1 –percentages do not add up to 100 due to missing data.
2 –adjusted for sex only.
3 –adjusted for age only.
4 –adjusted for age and sex.
https://doi.org/10.1371/journal.pone.0183817.t003
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Fig 3. Venn diagram of the prevalence of multimorbidity according to data source. (A) All data. (B) Hospitalised patients only.
Percentages (%) represent the proportion of all multimorbidity cases ascertained from any of the data sources. Venn diagram constructed
using EulerAPE: http://www.eulerdiagrams.org/eulerAPE/.
https://doi.org/10.1371/journal.pone.0183817.g003
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assigned to 29 chronic conditions that are present on admission, where the condition does not
meet the criteria for coding [52]. We anticipate that this introduction of supplementary codes
for chronic conditions will have a positive impact on the sensitivities calculated in the future
studies. For studies that do not have supplementary codes, it is advised to incorporate longer
lookback periods in order to increase ascertainment of chronic conditions in hospital data [10,
53].
We found that using medication data identifies more cases (higher sensitivity), but at the
cost of lower PPV. The lowest PPVs in medication data were found for stroke (16%) and heart
disease (35%), the definitions for both of which capture drugs with multiple indications for
prescribing. Strong levels of agreement for diabetes, hypertension and Parkinson’s disease are
consistent with previous research [41, 54–56], indicating that medication data can potentially
be used for capturing these conditions. Low sensitivity and agreement for cancer in our study
is congruent with previous Australian studies [54, 57], explained by the fact that chemotherapy
drugs are only captured in the PBS data whilst patients are undergoing active treatment. Ascer-
tainment of such cases can be increased by incorporating longer lookback periods. Higher sen-
sitivities for diabetes, hypertension and depression found in our study, compared with a
previous Australian study [57], could be attributable to a small sample size in that study, as
well as our modified list of depression medications. Namely, we excluded tricyclic antidepres-
sants, as they are commonly prescribed for insomnia and pain. This modification increased
our PPV from 55% to 66%.
Selection of the most appropriate set of chronic conditions for other studies will depend on
the study’s purpose and the availability of data. Studies requiring accurate case ascertainment
should use hospital data (noting that under-ascertainment is likely), or medication data for
conditions for which medications are indicated only for that condition (e.g. diabetes) and
where there is enough lookback time available. If a comprehensive profile of a patient’s mor-
bidity is needed, we suggest using a combination of data sources in order to increase sensitivity
for identifying certain conditions. Caution should be applied when using hospital data for
event-based conditions such as stroke, as these may have occurred outside of the time period
of data capture, and would thus be under-reported. Identification of stroke patients using
medications is also problematic, as the most commonly dispensed medication (Aspirin) is
used for a variety of purposes. Furthermore, we recommend caution when interpreting the
prevalence of disease or multimorbidity when using a single data source, in line with previ-
ously published work [26].
To the best of our knowledge, this is the first study to evaluate the differences in estimates
of multimorbidity, using the same list of chronic conditions and the same individuals. Previ-
ous data linkage studies have evaluated differences in estimates of chronic disease prevalence
within the same individuals [9, 55, 57–60], but did not formally compare case ascertainment of
multimorbidity. Pache et al. [24] assessed the prevalence of multimorbidity using three defini-
tions within the same sample, and found that one-third of participants diagnosed with multi-
morbidity were jointly diagnosed by all three definitions used. In our sample, this estimate was
lower (11% - 20%), but this is explained by the smaller number of chronic conditions (8 vs 27),
and the standardised list of chronic conditions used in our study, while Pache et al. used a dif-
ferent set of conditions in each of their three definitions,. Van den Bussche et al. [26] used an
identical list of chronic conditions in the same setting, albeit among different people, and
found that the prevalence of individual chronic conditions was one-third lower in claims data
than in primary care data.
The odds of multimorbidity in our study were found to be higher among males, those of
older age and those speaking a language other than English at home. The age gradient was
noticeable in both hospital and medication datasets, especially with older ages. However, the
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same gradient was not observed in the self-report data for those aged 85 and over, indicating a
possible under-ascertainment of multimorbidity when relying on self-report data only for this
age group. Males in our sample had between 7% (PBS data) and 49% (APDC data) higher
odds of multimorbidity than females. This is in contrast to other Australian studies, which
either found no difference [61] or higher prevalence among females [17], albeit there are dif-
ferences between the study samples in each of the studies. Compared with the current study,
the National Health Survey reported higher prevalence of the most common chronic condi-
tions–hypertension, heart disease and diabetes–among males aged 45 and over [62]. People
speaking a language other than English at home in our study were found to have increased
odds of having multimorbidity in the administrative data but decreased odds in the survey
data. These findings are novel, and have not been reported in the published literature, to the
best of our knowledge. A possible explanation is that those speaking another language might
have difficulties in understanding medical terminology, which translates to underreporting of
conditions in the survey data.
The use of a large-scale cohort study linked with administrative data is a particular strength
of our study. This allowed us to use a homogenous population and a common set of chronic
conditions to explore ascertainment of multimorbidity using different data sources, which, to
the best of our knowledge, has not been done before. Administrative data used in this study
are available in most Australian states and territories, allowing replication of results.
Our research has implications for studies examining chronic conditions from a single data
source and those examining multimorbidity. We have shown that agreement between self-
report and administrative data sources is generally poor, except for a handful of conditions,
implying that morbidity and multimorbidity prevalence estimates will vary depending on
which data are used. Caution should be applied whenever a single data source is used, taking
care to note different levels of capture of chronic disease between data sources. Self-report
studies are subject to recall bias, hospitalisation data can only capture conditions for those
admitted to hospital and if they are coded during the stay, and medication data may overesti-
mate certain conditions because drugs may have multiple indications. In the case of adminis-
trative data, extra care should be taken regarding the time period which is used to ascertain
morbidity, with longer times needed to capture more conditions of interest. Choice of which
data to use also depends on the purpose of the study. For example, if the aim of the study is to
monitor ‘active’ chronic conditions, data linkage of multiple administrative data sources may
be more useful than self-report of ever-diagnosis. Furthermore, our study’s finding regarding
different individuals, with different combinations of conditions being identified as multimor-
bid, depending on which datasets are used, poses a challenge when interpreting results of stud-
ies examining outcomes of multimorbidity. Careful consideration of individual conditions
(which may be under- or over-reported) is needed in order to provide meaningful recommen-
dations for patients with complex care needs.
Although this research generated interesting results, it has some limitations. We based the
analyses on a limited set of chronic conditions (arthritis and osteoporosis were notable omis-
sions) available in all three data sources, as well as the available lookback period length. The
prevalence of multimorbidity would have been different if a larger set of chronic conditions or
a longer lookback period was used. However, all of the conditions used in the current study
are National Health Priority Areas [63] as they represent the most common long-term condi-
tions and most commonly managed conditions by GPs [2], significantly contributing to the
burden of disease in the Australian community. They are also used in the majority of previ-
ously published research [64]. We have used the longest lookback period that the data allowed
(2 years), which is longer than the 1-year lookback used in some studies [54, 59].
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In the absence of readily available linked primary health care clinical data in Australia, and
due to different levels of capture of chronic diseases in administrative datasets, we have used
self-report chronic conditions as the reference when examining the concordance between data
sets. Although the use of self-report data for identification of chronic disease has been cau-
tioned by some [61], numerous other Australian studies use self-report data to ascertain multi-
morbidity [17–21]. Validation studies involving participants in the 45 and Up Study found
excellent levels of agreement between self-report diabetes [65], country of birth [66] and height
and weight [67]. Our data suggest that self-report may be less reliable after the age of 85 and in
people speaking a language other than English at home. The use of another data source as a
reference could have produced different results.
The use of administrative data poses a different set of challenges. Identification of chronic
conditions using APDC data is limited to people who have been admitted to hospital, and hav-
ing a chronic condition recorded if this was not directly related to the hospital stay, so it is
likely to identify only the most severe cases. Medication dispensing information is dependent
on the capture of data in the PBS dataset. We were limited to use of PBS-subsidised prescrip-
tion medicines, which does not include over-the-counter and private prescriptions.
Conclusions
As administrative data become more widely used for research and evaluation, it is increasingly
important to understand their strengths and limitations for ascertaining chronic disease and
multimorbidity. This study showed that administrative data has high predictive value for iden-
tifying some chronic conditions, but that sensitivity is generally low. Further, it showed that
different individuals, with different combinations of conditions, are identified as multimorbid
when different data sources are used. Research that explores specific disease combinations and
clusters of diseases that commonly co-occur, rather than simple disease counts, is likely to pro-
vide more useful insights into the complex care needs of individuals with multiple chronic
conditions.
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27. Violán C, Foguet-Boreu Q, Hermosilla-Pérez E, Valderas JM, Bolı́bar B, Fàbregas-Escurriola M, et al.
Comparison of the information provided by electronic health records data and a population health sur-
vey to estimate prevalence of selected health conditions and multimorbidity. BMC Public Health. 2013;
13(1):251.
28. Banks E, Redman S, Jorm L, Armstrong B, Bauman A, Beard J, et al. Cohort profile: the 45 and Up
Study. Int J Epidemiol. 2008; 37(5):941. https://doi.org/10.1093/ije/dym184 PMID: 17881411
29. The Sax Institute. The 45 and Up Study Questionnaires. https://www.saxinstitute.org.au/our-work/45-
up-study/questionnaires/. [Accessed 22 June 2017]
30. Mellish L, Karanges EA, Litchfield MJ, Schaffer AL, Blanch B, Daniels BJ, et al. The Australian Pharma-
ceutical Benefits Scheme data collection: a practical guide for researchers. BMC Res Notes. 2015;
8:634. https://doi.org/10.1186/s13104-015-1616-8 PMID: 26526064
31. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2016 [cited 23 August
2016]. http://www.whocc.no/atc_ddd_index/.
32. National Centre for Classification in Health. International Statistical Classification of Diseases and
Related Health Problems, 10th Revision, Australian Modification (ICD-10-AM), Australian Classification
of Health Interventions (ACHI). Sydney: National Centre for Classification in Health; 2006.
33. Kelman CW, Bass AJ, Holman CDJ. Research use of linked health data—a best practice protocol. Aust
N Z J Public Health. 2002; 26(3):251–5. PMID: 12141621
34. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity
in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373–83. PMID: 3558716
Multimorbidity in Australia: Comparing estimates derived using different data sources
PLOS ONE | https://doi.org/10.1371/journal.pone.0183817 August 29, 2017 16 / 18
35. Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the
Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol. 2004; 57(12):1288–94.
https://doi.org/10.1016/j.jclinepi.2004.03.012 PMID: 15617955
36. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data.
Med Care. 1998; 36(1):8–27. PMID: 9431328
37. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, et al. Coding algorithms for defining
comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005; 43(11):1130–9. PMID:
16224307
38. Lu CY, Barratt J, Vitry A, Roughead E. Charlson and Rx-risk comorbidity indices were predictive of mor-
tality in the Australian health care setting. J Clin Epidemiol. 2011; 64(2):223–8. https://doi.org/10.1016/j.
jclinepi.2010.02.015 PMID: 21172602
39. Sloan KL, Sales AE, Liu C-F, Fishman P, Nichol P, Suzuki NT, et al. Construction and characteristics of
the RxRisk-V: a VA-adapted pharmacy-based case-mix instrument. Med Care. 2003; 41(6):761–74.
https://doi.org/10.1097/01.MLR.0000064641.84967.B7 PMID: 12773842
40. Lix LM, De Coster C, Currie R. Defining and validating chronic diseases: an administrative data
approach: Manitoba Centre for Health Policy Winnipeg; 2006.
41. Halfon P, Eggli Y, Decollogny A, Seker E. Disease identification based on ambulatory drugs dispensa-
tion and in-hospital ICD-10 diagnoses: a comparison. BMC Health Serv Res. 2013; 13(1):453.
42. Huber CA, Szucs TD, Rapold R, Reich O. Identifying patients with chronic conditions using pharmacy
data in Switzerland: an updated mapping approach to the classification of medications. BMC Public
Health. 2013; 13(1):1030.
43. Vivas D, Guadalajara N, Barrachina I, Trillo J-L, Usó R, de-la-Poza E. Explaining primary healthcare
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